Factors affecting outcome in renal cell carcinoma
- PMID: 20592610
- DOI: 10.1097/MOU.0b013e32833c7b19
Factors affecting outcome in renal cell carcinoma
Abstract
Purpose of review: To review the latest status on prognostic factors in renal cell carcinoma (RCC).
Recent findings: Many predictive and prognostic factors can help differentiate between favorable and unfavorable RCC phenotypes. There currently exist several clinical and/or pathological, and biological factors, which have been exclusively tested and used in predictive and prognostic models. Nonetheless, the search for highly informative and reliable factors of disease characteristics and progression continues.
Conclusion: Over the last decade, an increase occurred in the number of models that can predict the treated natural history of RCC. Many of these novel models and previously developed models are tested in a head-to-head fashion, with the intent of identifying the most accurate and valuable tools for clinical practice. Novel prognostic factors and more up-to-date models are urgently needed for patients with metastatic RCC, especially in the era of targeted therapies. This should represent the focus of contemporary prognostic modeling in RCC.
Similar articles
-
Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.Eur Urol. 2011 Oct;60(4):644-61. doi: 10.1016/j.eururo.2011.06.041. Epub 2011 Jun 30. Eur Urol. 2011. PMID: 21741163 Review.
-
Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.J Urol. 2005 Jun;173(6):1853-62. doi: 10.1097/01.ju.0000165693.68449.c3. J Urol. 2005. PMID: 15879764 Review.
-
Prognostic factors in renal cell carcinoma.Semin Oncol. 2006 Oct;33(5):563-75. doi: 10.1053/j.seminoncol.2006.06.006. Semin Oncol. 2006. PMID: 17045085 Review.
-
Renal cell carcinoma.Curr Opin Oncol. 2009 May;21(3):266-71. doi: 10.1097/CCO.0b013e32832a05c8. Curr Opin Oncol. 2009. PMID: 19339887 Review.
-
Prognostic models and algorithms in renal cell carcinoma.Urol Clin North Am. 2008 Nov;35(4):613-25; vii. doi: 10.1016/j.ucl.2008.07.003. Urol Clin North Am. 2008. PMID: 18992615 Review.
Cited by
-
Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.World J Urol. 2016 Oct;34(10):1411-9. doi: 10.1007/s00345-016-1767-9. Epub 2016 Feb 15. World J Urol. 2016. PMID: 26879416
-
Vascularity of primary and metastatic renal cell carcinoma specimens.J Transl Med. 2013 Jan 14;11:15. doi: 10.1186/1479-5876-11-15. J Transl Med. 2013. PMID: 23316728 Free PMC article.
-
Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer.Cancer Manag Res. 2020 Sep 15;12:8481-8490. doi: 10.2147/CMAR.S264856. eCollection 2020. Cancer Manag Res. 2020. PMID: 32982441 Free PMC article.
-
Clinico-pathological prognostic factors of renal cell carcinoma: A 15-year review from a single center in Greece.Urol Ann. 2014 Apr;6(2):116-21. doi: 10.4103/0974-7796.130552. Urol Ann. 2014. PMID: 24833821 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials